Zymvol
5 known investors
ZymVol uses a physics-AI computational approach combining bioinformatics, molecular modelling, and AI to model enzyme function and predict biocatalyst performance in silico. It serves R&D teams across industries to accelerate enzyme engineering and biocatalysis campaigns by prioritizing top-performing candidates before lab work.
Investors · 5
Frequently asked questions
- What does Zymvol do?
- ZymVol uses a physics-AI computational approach combining bioinformatics, molecular modelling, and AI to model enzyme function and predict biocatalyst performance in silico. It serves R&D teams across industries to accelerate enzyme engineering and biocatalysis campaigns by prioritizing top-performing candidates before lab work.
- Who are Zymvol's investors?
- Zymvol's investors include Adara Ventures, Elaia, Faber, Faber Capital SCR SA, Übermorgen Ventures.